Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating DNA and lung cancer.

Xiaoyan Xue1, Yong M Zhu, Penella J Woll

  • 1Department of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, United Kingdom.

Annals of the New York Academy of Sciences
|November 17, 2006
PubMed
Summary

Early lung cancer detection is crucial. Research explores using circulating cell-free DNA with tumor-specific genetic and epigenetic changes for noninvasive diagnosis and patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetocardiography in the diagnosis of suspected ANOCA: a case series.

Frontiers in cardiovascular medicine·2026
Same author

Elucidating the multitarget neuroprotective mechanisms of protocatechuic acid in neurological disorders (Review).

Molecular medicine reports·2026
Same author

Genes associated with genetic and rare lung diseases and the risk of lung cancer.

BMC cancer·2026
Same author

Multifaceted Role of Copper Homeostasis in Gut Health: From Molecular Mechanisms to Therapeutic Interventions.

Cells·2026
Same author

Decoding the metabolic-immune axis for novel therapeutics in bladder cancer.

Biochimica et biophysica acta. Reviews on cancer·2026
Same author

Zinc supplementation in liver cirrhosis: meta-analysis of its effect on biochemical and clinical outcomes.

BMC nutrition·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is the leading cause of cancer death globally, with late diagnosis hindering curative treatment.
  • A noninvasive method for early lung cancer detection is urgently needed.
  • Elevated circulating cell-free DNA levels in lung cancer patients suggest potential diagnostic significance.

Purpose of the Study:

  • To review the evidence on circulating cell-free DNA in lung cancer.
  • To explore the diagnostic and prognostic significance of circulating DNA.
  • To consider future clinical applications of circulating DNA in patient management.

Main Methods:

  • Review of existing scientific literature on circulating cell-free DNA in lung cancer.
  • Analysis of genetic and epigenetic alterations in circulating DNA from lung cancer patients.
  • Evaluation of diagnostic sensitivity and specificity of circulating DNA markers.

Main Results:

  • Circulating cell-free DNA in lung cancer patients shows tumor-specific genetic and epigenetic changes.
  • These changes include chromosome loss, oncogene activation, and tumor-suppressor gene methylation.
  • The diagnostic and prognostic value of these circulating DNA alterations requires further clinical validation.

Conclusions:

  • Circulating cell-free DNA holds promise as a noninvasive biomarker for early lung cancer detection.
  • Further research is needed to establish the clinical utility of circulating DNA for diagnosis and patient management.
  • Investigating genetic and epigenetic changes in circulating DNA can guide future clinical applications.

Related Experiment Videos